Log In
Print
BCIQ
Print
Print this Print this
 

polmacoxib (formerly CG100649)

  Manage Alerts
Collapse Summary General Information
Company CrystalGenomics Inc.
DescriptionDual-acting cyclooxygenase-2 (COX-2) and carbonic anhydrase inhibitor
Molecular Target Cyclooxygenase-2 (COX-2) ; Carbonic anhydrase l (CAI)
Mechanism of ActionCyclooxygenase-2 (COX-2) inhibitor; NSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationOsteoarthritis
Indication DetailsTreat osteoarthritis (OA)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today